Cat. No.: X24-09-YM091
HSP inhibitor, Retaspimycin, Purity ≥98%
Synonym: 857402-23-4; IPI-504; [(4E,6Z,8S,9S,10E,12S,13R,14S,16R)-13,20,22-Trihydroxy-8,14-dimethoxy-4,10,12,16-tetramethyl-3-oxo-19-(prop-2-enylamino)-2-azabicyclo[16.3.1]docosa-1(21),4,6,10,18(22),19-hexaen-9-yl] carbamate; HSP inhibitor
- CAS Number: 857402-23-4
- Compound CID: 11534420
Product Size
1 mg; 5 mg; 10 mg; 20 mg
Properties
Description
Retaspimycin is an effective metabolism inhibitor, that has the ability to prevent the pathway of cell metabolism by inhibiting HSP. The molecular weight of the compound is 587.7, and its molecular formula is C31H45N3O8. It targets the GRP94 and HSP90.
Molecular Formula
C31H45N3O8
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Confirmed by NMR/HPLC/MS.
Applications
Retaspimycin plays a key role in reducing tumor growth and overcoming resistance to other therapies.
Related Products
-
HSP inhibitor, KOS953, Purity ≥98%
-
HSP inhibitor, 17-DMAG HCl, Purity ≥98%
-
HSP inhibitor, BIIB021, Purity ≥98%
-
HSP inhibitor, Elesclomol, Purity ≥98%
-
HSP inhibitor, AUY922, Purity ≥98%
-
HSP inhibitor, NVP-BEP800, Purity ≥98%
